Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
10.04
-0.07 (-0.69%)
Jan 17, 2025, 4:00 PM EST - Market closed
Bioventus Market Cap
Bioventus has a market cap or net worth of $656.29 million as of January 17, 2025. Its market cap has increased by 99.67% in one year.
Market Cap
656.29M
Enterprise Value
1.02B
1-Year Change
99.67%
Ranking
Category
Stock Price
$10.04
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $656.29M, a decrease of -8.01%. That is a compound annual growth rate of -2.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 656.29M | -4.38% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |